COVID-19 vaccination dry run in Uttar Pradesh from Tuesday

By: |
January 3, 2021 9:57 PM

In a statement, the government said the dry run will start at 10 am in three urban and as many rural sites with a minimum of two sessions.

Covid-19 vaccination driveIndia's drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.

A dry run to assess the readiness of the mechanism laid out for the imminent COVID-19 immunisation drive will be undertaken in six sites of Uttar Pradesh from January 5, the state government said on Sunday.

In a statement, the government said the dry run will start at 10 am in three urban and as many rural sites with a minimum of two sessions.

Issuing necessary guidelines to the divisional commissioners and district magistrates, Additional Chief Secretary, Health, Amit Mohan Prasad asked them to ensure that syringes, vaccine, AEFI (Adverse Event Following Immunization) kit and other logistics reach the session sites in time.

The waiting and observation areas should have proper sitting arrangements. It has to be ensured that the vaccination team reaches the site 45 minutes in advance, he said.

Prasad said sector officers will be appointed to ensure that the dry run sessions take place on time. These sector officers must inspect the sites one day in advance to ensure that the those are ready and have the necessary facilities.

The dry run session has to be conducted peacefully and smoothly. Security of vaccines has to be ensured during storage, transportation to site, and actual vaccination, he said.

“The beneficiaries should be informed to reach the site well in time,” Prasad added.

India’s drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.

The Drugs Controller General of India granted the approval on the basis of recommendations by a COVID-19 Subject Expert Committee of the Central Drugs Standard Control Organisation.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid-19 Vaccine Diplomacy: India starts vaccine delivery to 6 countries, more to follow; will this impact domestic roll-out?
2Covid 19 Vaccination in India Live Updates: India begins vaccine supply to six countries, more to follow
3Tamil Nadu seeks PM’s intervention in early sanction of fund for bulk drug park